Twice-yearly shot proves successful at preventing HIV infection …
WEBJul 24, 2024 · Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa.
Engineered Virus Steals Proteins From H.I.V., Pointing to New …
WEBAug 8, 2024 · Scientists have developed a new weapon against H.I.V.: a molecular mimic that invades a cell and steals essential proteins from the virus. A study published in Science on Thursday reported...
A two-dose schedule could make HIV vaccines more effective
WEB20 hours ago · Researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later. Date: September 20, 2024. Source: Massachusetts Institute ...
HIV: how close are we to a vaccine — or a cure? - Nature
WEBSep 2, 2024 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
New HIV drug can only offer hope of ending AIDS if all have …
WEBJul 10, 2024 · New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says. GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention.
A two-dose schedule could make HIV vaccines more effective
WEB22 hours ago · Each year, HIV infects more than 1 million people around the world, and some of those people do not have access to antiviral drugs. An effective vaccine could prevent many of those infections. One promising vaccine now in clinical trials consists of an HIV protein called an envelope trimer, along with a nanoparticle called SMNP.
Long-Acting Drugs May Revolutionize H.I.V. Prevention and …
WEBApr 17, 2024 · The drug is in multiple late-stage trials as a long-acting H.I.V. preventative in various groups, including cisgender women. Lenacapavir is also being tested as a treatment in the form of a...
FDA Approves New HIV Drug for Adults with Limited Treatment …
WEBJan 4, 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
After decades of failures, researchers have renewed hopes for an ...
WEBMar 6, 2024 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
Encouraging First-in-Human Results for a Promising HIV Vaccine
WEBJun 8, 2023 · The team, with NIH collaborators and support, has been plotting out a stepwise approach to train the immune system into making the needed bnAbs that recognize many HIV variants. The critical first step is to prime the immune system to make more of those coveted bnAb-precursor B cells.